Dr. Andrew Y. Koh received his bachelor’s degree in Biology from Harvard College. He was then awarded a Rhodes Scholarship and studied English Literature at Pembroke College, Oxford University. Dr. Koh obtained his MD degree from Harvard Medical School. He completed internship, residency, and chief residency at Children’s Hospital, Boston. He then completed a dual fellowship in hematology/oncology and infectious diseases at Children’s Hospital, Boston, and Dana Farber Cancer Institute. After serving as an attending physician on both the hematopoeitic stem cell transplantation service and immuncompromised infectious diseases service for five years, Dr. Koh left Harvard to become Director of Pediatric Hematopoeitic Stem Cell Transplantation at the University of Texas Southwestern Medical Center in 2009.


Medical School
Harvard Medical School (1996)
Children's Hospital of Boston - Pediatric Program (1999), Pediatric Medicine
Children's Hospital of Boston - Pediatric Program (2000), Pediatric Medicine
Children's Hospital Boston - Infectious Disease (2004), Pediatric Infectious Diseases
Children's Hospital Boston - Hematology/Oncology (2004), Pediatric Hematology/oncology

Research Interest

  • Candida albicans pathogenesis
  • Gut Microbiota (bacterial-fungal interactions)
  • Host pathogen interactions
  • Intestinal graft-versus-host-disease
  • Pseudomonas aeruginosa pathogenesis


Featured Publications LegendFeatured Publications

Food for Gut: Microbiota Fuels Immune Reconstitution after BMT.
Simms-Waldrip TR, Koh AY Cell Host Microbe 2018 Apr 23 4 423-424
Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients.
Frankel AE, Coughlin LA, Kim J, Froehlich TW, Xie Y, Frenkel EP, Koh AY Neoplasia 2017 Oct 19 10 848-855
Potential for Monitoring Gut Microbiota for Diagnosing Infections and Graft-versus-Host Disease in Cancer and Stem Cell Transplant Patients.
Koh AY Clin. Chem. 2017 Jul
The microbiome in hematopoietic stem cell transplant recipients and cancer patients: Opportunities for clinical advances that reduce infection.
Koh AY PLoS Pathog. 2017 Jun 13 6 e1006342
Antibiotic-Induced Depletion of Anti-Inflammatory Clostridia is Associated with the Development of GVHD in Pediatric Stem Cell Transplant Patients.
Simms-Waldrip TR, Sunkersett G, Coughlin LA, Savani MR, Arana C, Kim J, Kim M, Zhan X, Greenberg DE, Xie Y, Davies SM, Koh AY Biol. Blood Marrow Transplant. 2017 Feb
FMAP: Functional Mapping and Analysis Pipeline for metagenomics and metatranscriptomics studies.
Kim J, Kim MS, Koh AY, Xie Y, Zhan X BMC Bioinformatics 2016 Oct 17 1 420


Featured Books Legend Featured Books

Honors & Awards

  • Eleanor and Miles Shore Scholar
  • Glaser Pediatric Research Network Fellowship Award
  • Rhodes Scholarship

Professional Associations/Affiliations

  • American Society for Pediatric Hematology/Oncology (2012)
  • American Society of Hematology (2010)
  • Society for Pediatric Research (2010)
  • American Society for Blood and Marrow Transplantation (2009)
  • American Society for Microbiology (2003)